The EPS beat and improving EBITDA trajectory may support near-term price, but the 18% revenue decline and below-prior-year full-year guidance signal secular headwinds. Watch for Q2 results and progress toward Q4 2026 cash flow breakeven.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 6 $6.99entry
- T+1 · 6mo ago +8.44%α +8.77% · $7.58
- T+5 · 6mo ago +12.86%α +11.73% · $7.89
- T+20 · 6mo ago +21.01%α +18.23% · $8.46
- T+60 · 4mo ago +55.06%α +53.99% · $10.84
Price Chart
How similar events traded
Executive Summary
Amwell reported Q1 2026 revenue of $54.9M (down 18% YoY) but beat consensus estimates on both EPS ($-0.66 vs $-0.77) and revenue ($54.9M vs $51.5M). Adjusted EBITDA loss narrowed to $3.1M, and full-year 2026 guidance for adjusted EBITDA was improved, though revenue guidance remains unchanged at $195-205M.
Key Financial Metrics
Key Facts
- Q1 2026 revenue $54.9M, down 18% from $66.8M in Q1 2025
- GAAP EPS $-0.66 vs consensus $-0.77 (beat by 14.3%)
- Adjusted EBITDA loss improved to $3.1M from $10.3M in Q4 2025
- Full-year 2026 revenue guidance reaffirmed at $195-205M, well below 2025 revenue of $249M
- Full-year 2026 adjusted EBITDA guidance improved to ($16M)-($12M) from ($24M)-($18M)
- Q2 2026 revenue guidance $48-52M, adjusted EBITDA ($4M)-($2M)
- Cash and securities $180M, net cash used in operations improved to $1M from $25M YoY
Financial Impact
Revenue miss on a YoY basis but beat consensus; EPS beat driven by cost reduction; guidance implies continued top-line contraction.
Risk Factors
- Continued revenue decline as 2026 guidance implies further contraction
- Dependence on DHA contract renewal beyond July 2026
- High cash burn despite improvement; breakeven target dependent on cost control
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-206427 |
| Document: amwl-20260505.htm | 0001193125-26-206427 |
| Document: 0001193125-26-206427-index-headers.html | 0001193125-26-206427 |
| Document: 0001193125-26-206427-index.html | 0001193125-26-206427 |
| Document: 0001193125-26-206427.txt | 0001193125-26-206427 |
| 8-K Data (Synthetic) | 0001193125-26-206427 |
Track record
18 reports on AMWL
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago DEFA14A Neutral 3/10 Entry $11.74 Now $11.34 −3.41% settles Feb 11
- Nov 13, 20263d ago DEF 14A Neutral 3/10 Entry $11.74 Now $11.34 −3.41% settles Feb 11
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $12.35 Now $11.34 −8.18% settles Feb 2
- Oct 5, 20266w ago Insider Cluster Neutral 3/10 Entry $12.27 Now $11.34 −7.58% settles Dec 31
- Oct 1, 20266w ago 144 Neutral 2/10 Entry $12.39 Now $11.34 −8.47% settles Dec 29
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $12.99 Now $11.34 −12.70% settles Dec 1
- Aug 4, 202614w ago 8-K Mixed 6/10 Entry $13.02 to $14.91 Now $11.34 −12.90% ▲ +14.52% +14.32% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $9.25 to $13.44 Now $11.34 +22.59% ▲ +45.30% +42.50% vs SPY
- Jul 1, 202619w ago 144 Neutral 2/10 Entry $9.25 to $13.47 Now $11.34 +22.59% ▲ +45.62% +42.61% vs SPY
- Jun 9, 202622w ago DEFA14A Neutral 3/10 Entry $8.50 to $12.82 Now $11.34 +33.41% ▲ +50.84% +47.02% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers